miércoles, 15 de julio de 2026

FDA grants traditional approval to selpercatinib for locally advanced or metastatic RET fusion-positive solid tumors

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-traditional-approval-selpercatinib-locally-advanced-or-metastatic-ret-fusion-positive?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario